Q&A with FDA

U.S. Food and Drug Administration, Center for Drug Evaluation and Research

"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Q&A with FDA" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Q&A with FDA

Episodes (20)

Dec 4, 2024 Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
Oct 29, 2024 Understanding Drug Recalls with Dr. Ileana Elder
Sep 27, 2024 Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim

Q&A with FDA

Dec 4, 2024
14 minutes
19 MB

Q&A with FDA: Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

Q&A with FDA

Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

U.S. Food and Drug Administration, Center for Drug Evaluation and Research

00:00 -14:00